Mammoth Biosciences develops novel CRISPR applications for disease detection, research, agriculture, biodefense, and more.
Mammoth Biosciences has raised $95.0M in total funding. The most recent round was Corporate Round. The last funding was announced in April 2024.
Mammoth Biosciences's investors include Mayfield Fund, SV Angel, 8VC, Amazon, Sixth Street.
Mammoth Biosciences is headquartered in San Francisco, United States.
Mammoth Biosciences develops novel CRISPR applications for disease detection, research, agriculture, biodefense, and more.
Mammoth Biosciences is at the Corporate Round stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Mammoth Biosciences — Funding & Investors." VCBacked, April 25, 2024, https://www.vcbacked.co/company/mammoth-biosciences. Accessed November 12, 2026.
VCBacked. (2024). Mammoth Biosciences — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/mammoth-biosciences
{{cite web |title=Mammoth Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/mammoth-biosciences |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Mammoth Biosciences? Request a listing update